BD Appoints Ferass Abuzaina as New Worldwide President of Surgery

BD Appoints Ferass Abuzaina as Worldwide President of Surgery

In a significant move, BD (Becton, Dickinson and Company), a leader in global medical technology, has appointed Ferass Abuzaina as the new worldwide president of its Surgery business unit, effective immediately. This strategic appointment is poised to drive growth and further enhance BD's reputation in surgical innovation and operational excellence.

A Strong Leadership Background

Ferass Abuzaina takes on this pivotal role after serving as the Worldwide VP/GM for Advanced Repair and Reconstruction within the Surgery division at BD. With a professional journey that began at BD in 2013, he has held various leadership positions that span across research and development, business strategy, and commercial development. His extensive experience within the company has made him a key player in advancing the Surgery division's innovation pipeline and overall performance.

Peter Menziuso, executive vice president and president of the Interventional segment at BD, expressed confidence in Abuzaina's ability to lead, stating, "Surgery is well-positioned for its next chapter of growth, and Ferass is the right leader to help us build on that momentum. He combines a deep understanding of our business with a strong commitment to innovation, execution, and serving customers. I am confident his leadership will help us continue advancing solutions that improve outcomes for patients and clinicians around the world."

Educational Credentials

Abuzaina holds a Bachelor of Science, a Master of Science, and a Ph.D. in Chemical Engineering from the Tandon School of Engineering at New York University. In addition, he earned a Master of Business Administration from the University of Connecticut School of Business, equipping him with a robust blend of technical and managerial expertise suitable for leading BD’s Surgery unit.

BD's Vision and Impact

BD stands as one of the largest pure-play medical technology companies globally, committed to advancing health by driving innovation in medical essentials, connected care, biopharma systems, and interventional solutions. The company’s mission is to support healthcare professionals on the frontlines by offering transformative technologies, services, and solutions that optimize clinical operations and improve patient care.

With over 60,000 employees around the world, BD delivers billions of products every year that have a lasting and positive impact on global healthcare. By closely collaborating with healthcare partners, BD aims to enhance health outcomes, reduce costs, increase clinical efficiency, improve safety, and expand access to healthcare solutions.

As Ferass Abuzaina steps into this critical role, all eyes will be on BD’s Surgery unit as it embarks on its next growth phase under his guidance. His track record of fostering innovation and operational success signals a promising future for BD’s initiatives in medical technology and patient care.

For more information about BD, please visit their official website or connect with them on social media platforms like LinkedIn.